-
1 Comment
HLB Life Science Co.Ltd is currently in a long term downtrend where the price is trading 47.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
HLB Life Science Co.Ltd's total revenue sank by 31.9% to $19B since the same quarter in the previous year.
Its net income has dropped by 373.4% to $-44B since the same quarter in the previous year.
Finally, its free cash flow grew by 103.0% to $112M since the same quarter in the previous year.
Based on the above factors, HLB Life Science Co.Ltd gets an overall score of 2/5.
| Exchange | KO |
|---|---|
| CurrencyCode | KRW |
| Industry | Other |
| Sector | Other |
| ISIN | KR7067630004 |
| Market Cap | None |
|---|---|
| PE Ratio | nan |
| Target Price | nan |
| Dividend Yield | nan% |
| Beta | nan |
None
Here's how to backtest a trading strategy or backtest a portfolio for 067630.KO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
